PITTSBURGH - TelAve -- SNS Intelligence announced the official launch of the SNS Market Intelligence Platform, a next-generation solution designed to replace static reports with an interactive market intelligence portal. The platform delivers structured market and drug development pipeline data through a cloud-based dashboard featuring advanced filters, slicers, and dynamic visualizations.

SNS Market Intelligence Platform Key Features:

• Clinical and late-stage pipeline tracking: Comprehensive tracking of assets from preclinical through pre-registration, structured to support portfolio planning and competitive intelligence.
• Market size estimates and long-term forecasts covering Therapeutic Category, Drug Delivery Route, Drug Type, Distribution Channel, Drug Class, Regional & Country markets
• • Analyze the data using filters, slicers and time ranges to understand the market landscape.
• Visualizations designed to support strategic planning and investment decisions.

The SNS Market Intelligence Platform consolidates years of proprietary research into a single, unified interface built for biopharma strategy, business development, competitive intelligence, and investment teams. Users can interrogate market size and forecast data by geography, subsegments and at country level. Key pipeline candidates are also presented in a structured graphical format displaying molecule type, mechanism of action, and clinical stage, enabling rapid identification of white-space opportunities and strategic inflection points.

More on TelAve News

• Aleen Inc. (C S E: ALEN.U) Advances Digital Wellness Vision with Streamlined Platform Navigation and Long-Term Growth Strategy
• RimbaMindaAI Officially Launches Version 3.0 Following Strategic Breakthrough in Malaysian Market Analysis
• Fed Rate Pause & Dow 50k: Irfan Zuyrel on Liquidity Shifts, Crypto Volatility, and the ASEAN Opportunity
• 20/20 Institute Launches Updated Vision Correction Procedures Page for Denver & Colorado Springs
• OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors

The launch is led by a comprehensive Dermatology In Sight module, with two focus areas: Psoriasis & Skin Cancer, and an active expansion roadmap that includes upcoming datasets on Ophthalmology (Retinal and Glaucoma), Cell & Gene Therapies, Biosimilars, and GLP-1 therapies.

Dermatology In Sight Module: Unmatched Visual Granularity
The inaugural Dermatology module provides high-resolution mapping of the global therapeutic market forecasts, segmented by mechanism of action and molecular class to deliver a precise view of competitive dynamics.

Availability and Free Trial
The SNS Market Intelligence Platform is available via annual subscription, with tiered access designed to support both emerging biotech companies and global pharmaceutical organizations. SNS Intelligence is offering a free limited trial to showcase the platforms capabilities. The Dermatology module is now live and available for a free trial via

https://www.snsintel.com/

More on TelAve News

• New Children's Picture Book "Diwa of Mount Luntian" Focuses on Calm, Culture, and Connection for Today's Families
• Actor, Spokesperson Rio Rocket Featured in "Switch to AT&T" Campaign Showing How Customers Can BYOD and Keep Their Number
• The World's No.1 Superstar® Brings Disco Fever Back With New Global Single and Video "Disco Dancing"
• Boston Industrial Solutions' Natron® 512N Series UV LED Ink Achieves BPA Certification, Advancing Safe and Sustainable Digital Printing
• Joan Nissen promoted to Century Fasteners Corp. – General Manager, Aerospace & Government Sales

About SNS Intelligence
SNS Intelligence is global market intelligence firm focused exclusively on healthcare and life sciences. By combining deep domain expertise with rigorous data structuring and advanced visualization, SNS Intelligence enables organizations to make informed decisions in complex and rapidly evolving markets.